देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
Enrofloxacin
Elanco GmbH
QJ01MA90
Enrofloxacin
25 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
enrofloxacin
Authorised
1988-10-01
Health Products Regulatory Authority SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Baytril 25 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One ml solution contains: ACTIVE SUBSTANCE: Enrofloxacin 25 mg EXCIPIENT: n-Butyl alcohol 30 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. Clear light-yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs, cats, pigs (piglets), rabbits, rodents, reptiles and ornamental birds. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Dogs Treatment of infections of the alimentary, respiratory and urogenital tracts (including prostatitis, adjunctive antibiotic therapy for pyometra), skin and wound infections, otitis (externa/media) caused by enrofloxacin susceptible strains of: _Staphylococcus _ spp_., Escherichia coli, Pasteurella _spp_., Klebsiella _spp_., Bordetella _spp_., Pseudomonas _spp_. _and _Proteus _spp_. _ _ _ Cats Treatment of infections of the alimentary, respiratory and urogenital tracts (as adjunctive antibiotic therapy for pyometra), skin and wound infections, caused by enrofloxacin susceptible strains of: _Staphylococcus _spp_., Escherichia coli, Pasteurella _spp_., _ _Klebsiella _spp_., Bordetella _spp_., Pseudomonas _spp_. _and _Proteus _spp. Pigs (piglets) Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of: _Pasteurella multocida, Mycoplasma _ spp_., Actinobacillus pleuropneumoniae_. Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of _Escherichia coli. _ Treatment of septicaemia caused by enrofloxacin susceptible strains of _Escherichia coli_. Rabbits Treatment of infections of the alimentary and respiratory tracts caused by enrofloxacin susceptible strains of: _Escherichia coli_, _Pasteurella multocida _and _Staphylococcus _spp. Treatment of skin and wound infections caused byenrofloxacin susceptible strains of _Staphylococcus aureus. _ _ _ Rodents, repti पूरा दस्तावेज़ पढ़ें